High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
Adrian Gervais, Astrid Marchal, Alexis Maillard, Tom Le Voyer et autres
Patients with myasthenia gravis (MG) may produce autoantibodies neutralizing type I interferons (AAN-I-IFN), which underlie severe viral diseases, including critical COVID-19 pneumonia, in patients without MG. We studied an international cohort of 85 unvaccinated SARS-CoV-2-infected MG patients not given antiviral treatment. Hypoxemic …
fr, ca, us, se, es, nl, br, Tunisie, de (code pays fourni par la source)
0 citations
Proceedings of the National Academy of Sciences